Abitare In S.p.A. logo

Abitare In S.p.A. (ABT)

Market Closed
1 Aug, 15:30
XMIL XMIL
2. 88
-0.08
-2.87%
- Market Cap
36.49 P/E Ratio
2.2% Div Yield
7,874 Volume
4.44 Eps
2.96
Previous Close
Day Range
2.88 2.98
Year Range
2.5 4.7
Want to track ABT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 73 days

Summary

ABT closed today lower at €2.88, a decrease of 2.87% from yesterday's close, completing a monthly decrease of -5.88% or €0.18. Over the past 12 months, ABT stock lost -32.55%.
ABT pays dividends to its shareholders, with the most recent payment made on May 15, 2025. The next announced payment will be in In 1 weeks on Aug 15, 2025 for a total of €0.59.
The last earnings report, released on Jul 17, 2025, exceeded the consensus estimates by 0.02%. On average, the company has fell short of earnings expectations by -0.41%, based on the last three reports. The next scheduled earnings report is due on Oct 14, 2025.
Abitare In S.p.A. has completed 8 stock splits, with the recent split occurring on Jan 02, 2013.
The company's stock is traded on 16 different exchanges and in various currencies, with the primary listing on NYSE (USD).

ABT Chart

Chart

Chart with 60 data points.
The chart has 1 X axis displaying categories.
The chart has 2 Y axes displaying values, and values.
End of interactive chart.
3 Dividend Growth Stocks That Will Deliver Meaty Returns After 5 Years

3 Dividend Growth Stocks That Will Deliver Meaty Returns After 5 Years

Sufficient earnings growth to continually increase dividends at a comfortably low payout  ratio that also accommodates expansion capex is an excellent signal for strong upside potential.

247wallst | 4 days ago
Best Dividend Aristocrats For August 2025

Best Dividend Aristocrats For August 2025

Dividend Aristocrats are outperforming SPY in July but still trail year-to-date; select Aristocrats delivered double-digit gains and strong dividend growth. 47 of 69 Aristocrats raised dividends in 2025, with an average growth rate of 4.92% and more increases expected, signaling ongoing income reliability. My 'Promising Aristocrats' list, focused on undervaluation and projected total return, has outperformed both NOBL and SPY since late June.

Seekingalpha | 4 days ago
Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know

Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know

Zacks.com users have recently been watching Abbott (ABT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Zacks | 1 week ago

Abitare In S.p.A. Dividends

Abbott Laboratories logo
ABT 2 weeks ago
Announced
Quarterly
$0.59 Per Share
Abbott Laboratories logo
ABT 3 months ago
Paid
Quarterly
$0.59 Per Share
Abbott Laboratories logo
ABT 6 months ago
Paid
Quarterly
$0.59 Per Share
Abbott Laboratories logo
ABT 9 months ago
Paid
Quarterly
$0.55 Per Share
Abbott Laboratories logo
ABT 15 Jul 2024
Paid
Quarterly
$0.55 Per Share

Abitare In S.p.A. Earnings

15 Oct 2025 (In 2 months) Date
1.3
Cons. EPS
-
EPS
14 Oct 2025 (In 2 months) Date
1.34
Cons. EPS
-
EPS
17 Jul 2025 Date
0.99
Cons. EPS
1.01
EPS
16 Jul 2025 Date
1.25
Cons. EPS
-
EPS
15 Apr 2025 Date
-
Cons. EPS
-
EPS
Abbott Laboratories logo
ABT 2 weeks ago
Announced
Quarterly
$0.59 Per Share
Abbott Laboratories logo
ABT 3 months ago
Paid
Quarterly
$0.59 Per Share
Abbott Laboratories logo
ABT 6 months ago
Paid
Quarterly
$0.59 Per Share
Abbott Laboratories logo
ABT 9 months ago
Paid
Quarterly
$0.55 Per Share
Abbott Laboratories logo
ABT 15 Jul 2024
Paid
Quarterly
$0.55 Per Share
15 Oct 2025 (In 2 months) Date
1.3
Cons. EPS
-
EPS
14 Oct 2025 (In 2 months) Date
1.34
Cons. EPS
-
EPS
17 Jul 2025 Date
0.99
Cons. EPS
1.01
EPS
16 Jul 2025 Date
1.25
Cons. EPS
-
EPS
15 Apr 2025 Date
-
Cons. EPS
-
EPS

Abitare In S.p.A. (ABT) FAQ

What is the stock price today?

The current price is €2.88.

On which exchange is it traded?

Abitare In S.p.A. is listed on NYSE.

What is its stock symbol?

The ticker symbol is ABT.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 2.2%.

What is its market cap?

As of today, no market cap data is available.

What is the earnings per share?

The EPS is 1.34.

When is the next earnings date?

The next earnings report will release on Oct 14, 2025.

Has Abitare In S.p.A. ever had a stock split?

Abitare In S.p.A. had 8 splits and the recent split was on Jan 02, 2013.

Abitare In S.p.A. Profile

Medical - Devices Industry
Healthcare Sector
Robert B. Ford CEO
XMIL Exchange
US0028241000 ISIN
US Country
114,000 Employees
15 Jul 2025 Last Dividend
2 Jan 2013 Last Split
13 Jan 1978 IPO Date

Overview

Abbott Laboratories is a global healthcare company that engages in the discovery, development, manufacturing, and sale of a wide range of health care products. With its foundation laid in 1888, and headquartered in North Chicago, Illinois, the company has established a significant presence worldwide. Abbott operates across four main sectors: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices, catering to a diverse range of healthcare needs from generic pharmaceuticals to advanced medical devices.

Products and Services

Abbott Laboratories offers a comprehensive portfolio of products and services across various healthcare domains:

  • Generic Pharmaceuticals: Includes treatments for pancreatic exocrine insufficiency, irritable bowel syndrome, biliary spasm, intrahepatic cholestasis, depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease, vestibular vertigo, pain, fever, inflammation, migraine, anti-infective clarithromycin, influenza vaccine, and colon rhythm regulation products.
  • Diagnostic Products: Offers laboratory and transfusion medicine systems in areas such as immunoassay, clinical chemistry, hematology, and transfusion. Includes molecular diagnostics for DNA and RNA processing and detection of infectious agents, point-of-care systems, blood gas testing cartridges, rapid diagnostics, molecular point-of-care testing for several diseases, cardiometabolic tests, drug and alcohol tests, remote patient monitoring, consumer self-tests, and laboratory automation and informatics solutions.
  • Nutritional Products: Provides nutritional products for both pediatric and adult use, catering to the specific dietary needs of different age groups and health conditions.
  • Medical Devices: Offers a wide array of devices for the treatment of cardiovascular diseases, including rhythm management, electrophysiology, heart failure, vascular, and structural heart devices. Additionally, the company develops diabetes care products such as blood glucose monitoring systems, along with neuromodulation devices for managing chronic pain and movement disorders.

Contact Information

Address: 100 Abbott Park Road
Phone: 224 667 6100